Tagged: bionure

June 27, 2017 @ 8:26 am By Erin Hobey  |  

Capital Cell, reportedly Europe’s first equity crowdfunding platform specializing in life science, has been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017. Capital Cell has been trading in Spain for just over 2 years, successfully closing 14 life… Read More

March 28, 2017 @ 11:14 am By Erin Hobey  |  

Bionure, a Spanish biotech company developing a  first-in-class drug for the treatment of multiple sclerosis, is currently 115% overfunding on Capital Cell. With more than €1,100,246 raised, Bionure has broken the record for the highest amount raised on a Spanish life science equity crowdfunding platform. Valued at… Read More

March 1, 2017 @ 5:53 am By Erin Hobey  |  

Valued at 9,400,000€, Bionure is overfunding on Capital Cell, raising more than 975,422€ from over 210 investors for 9.27% equity for its neuroprotector and myelin regenerator drug which treat Multiple Sclerosis. Bionure is a biotech-based company that is developing a new drug for the treatment of multiple sclerosis, a… Read More